carbamazepine has been researched along with Impairment, Light Touch Sensation in 1 studies
Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fabry's disease is an X-linked multisistemic lisosomal storage disorder caused by deficiency or absence in α-Galatosidase A." | 1.48 | [Neuropathy and Fabry's disease. Report of five cases]. ( Jara, P; Matamala, JM; Verdugo, R, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jara, P | 1 |
| Matamala, JM | 1 |
| Verdugo, R | 1 |
1 other study available for carbamazepine and Impairment, Light Touch Sensation
| Article | Year |
|---|---|
[Neuropathy and Fabry's disease. Report of five cases].
Topics: Adult; Analgesics, Non-Narcotic; Carbamazepine; Enzyme Replacement Therapy; Fabry Disease; Female; H | 2018 |